A message from Schulz Electric

Schulz Electric™ Refurbishes Critical Circulating Water Pump Motor in Only Four Days

Astatine-211 targets blood-borne cancers in Seattle clinical trials

September 13, 2022, 9:30AMNuclear News

A clinical dose of At-211 is prepared at the University of Washington for use in a Fred Hutchison Cancer Center clinical trial. (Photo: UW/Don Hamlin)

Scientists in the Departments of Radiation Oncology and Medicine at the University of Washington (UW) and Fred Hutchinson Cancer Center (Fred Hutch) are directly targeting cancerous cells traveling through patients’ bloodstreams with diseases such as leukemia and lymphoma using an intravenous injection of the radioactive isotope astatine-211 (At-211). The work, its challenges, and its promise were described in a recent news release from the National Isotope Development Center (NIDC), which is managed by the Department of Energy’s Isotope Program.

To continue reading, log in or create a free account!

A message from Exosens

High temperature fission chambers engineered for AMR/SMR safety and performance

Learn More

Deep Fission raises $30M in financing

September 8, 2025, 3:13PMNuclear News

Since the Department of Energy kicked off a 10-company race with its Nuclear Reactor Pilot Program to bring test reactors on line by July 4, 2026, the industry has been waiting for new...

U.S. nuclear fuel recycling takes two steps forward

September 8, 2025, 7:00AMRadwaste Solutions

Late last week saw two announcements from companies working to recycle used nuclear fuel on a commercial scale, providing welcome news to anyone hoping to see the United States move to unlock...

DOE awards $35M to help commercialize national lab technologies

September 5, 2025, 12:00PMNuclear News

The Department of Energy announced recently it will provide more than $35 million for 42 projects to help move emerging energy technologies from DOE national laboratories, plants, and sites...

Aalo breaks ground in Idaho

September 3, 2025, 7:01AMNuclear News

Eight days after Aalo Atomics released the details of its securing of $100 million in Series B funding, the company announced that it has broken ground on the 50-MWe Aalo-X. Sited in the...

Nuclear power on the moon: What we’re watching

September 2, 2025, 12:00PMNuclear News

After the Trump administration’s new push to get a nuclear reactor on the moon by 2030 was first reported by Politico last month, media played up the shock value for people new to the...

Powering the future: How the DOE is fueling nuclear fuel cycle research and development

August 29, 2025, 2:55PMNuclear NewsDaniel E. Rodriguez and Supathorn Phongikaroon

As global interest in nuclear energy surges, the United States must remain at the forefront of research and development to ensure national energy security, advance nuclear technologies, and...

DOE allocates HALEU to Antares, Standard Nuclear, and ACU/Natura

August 27, 2025, 12:00PMNuclear News

The Department of Energy made conditional commitments yesterday to provide high-assay low-enriched uranium to three companies: reactor developer Antares Nuclear; fuel fabricator Standard...

NRC, DOE to hold webinar on HALEU fuel cycle

August 22, 2025, 7:01AMNuclear News

The Nuclear Regulatory Commission and the Department of Energy will hold a webinar on August 27 from 1:00 p.m. to 4:00 p.m. (EDT) to discuss commercial-scale facility and transportation...

Aalo secures $100 million in Series B funding

August 20, 2025, 12:00PMNuclear News

It was near-certain that more good news was on the horizon for some of the 10 companies recently selected for the Department of Energy’s Nuclear Reactor Pilot Program. Now, only one week...

EPA approves expanded waste storage at WIPP

August 20, 2025, 9:30AMRadwaste Solutions

The Environmental Protection Agency has approved the addition of two new waste emplacement panels at the Waste Isolation Pilot Plant, the Department of Energy’s geologic repository for...

Astatine-211 targets blood-borne cancers in Seattle clinical trials

Related Articles